Compare two planned injectable plans and a proposed sublingual semaglutide ODT option. Enrollment has not opened. An independent licensed physician determines whether any future treatment is appropriate.
Three options to explore.
Compare two injection plans and a planned sublingual option; enrollment has not opened and the sublingual medication is not available for purchase through Majesta. Your physician determines whether any treatment is appropriate.
Enrollment has not opened. Join early access without payment or a medication order.
Semaglutide Injection
Plan pricing
Then $299/month. Cancel anytime.
Includes a $20 medical consultation fee with your licensed physician.
Weekly compounded semaglutide injection plan, prescribed only when a licensed physician determines it is appropriate.
Tirzepatide Injection
Plan pricing
Then $439/month. Cancel anytime.
Includes a $20 medical consultation fee with your licensed physician.
Weekly compounded tirzepatide injection. Dual GIP and GLP-1 receptor agonist. Your physician decides whether this mechanism fits your history and goals.
Sublingual Semaglutide ODT
Proposed launch pricing
Then $249 per approved care cycle.
Compounded medications are not FDA-approved.
A compounded sublingual orally disintegrating tablet option being prepared for clinician review.
Enrollment has not opened. This medication is not available for purchase through Majesta. Final availability, pricing, and terms will be confirmed before enrollment.
Join the WaitlistFinal plan and dose are determined by your physician.
See full plan comparison and FAQsCompounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers, which are not affiliated with and do not endorse Majesta Health. Those are separate FDA-approved products that we do not sell, and they are named here only to make that distinction clear. Results may vary. Not a substitute for professional medical advice.
The injectable plan prices include physician review, medication, shipping, and support. Sublingual pricing and terms are proposals, to be confirmed before enrollment.
Compounded preparations are prepared to United States Pharmacopeia (USP) standards and are dispensed under a physician's prescription by our dispensing pharmacy partner, Belmar Pharma Solutions, a state-licensed 503A compounding pharmacy. Compounded medications are not FDA-approved as final products and are not generic versions of or interchangeable with any brand-name medication.
| Option | First Month | Ongoing | What's Included |
|---|---|---|---|
| Majesta Health Essential Semaglutide injection | $179 | $299/mo | Doctor, medication, shipping, support. |
| Majesta Health Performance Tirzepatide injection | $339 | $439/mo | Doctor, medication, shipping, support. |
| Majesta Health Express Sublingual semaglutide ODT, planned option Enrollment has not opened. This medication is not available for purchase through Majesta. | $199 Proposed first care cycle | $249 Per approved care cycle, proposed | Final availability, pricing, and terms will be confirmed before enrollment. |
Injectable pricing is all-in per month. Sublingual pricing is proposed. See full cost breakdown or read what compounded semaglutide is and how it is regulated.
No surprise charges. No upcharges. Real medical care, honestly priced.
Real doctors, licensed in your state, available by message throughout your treatment.
Your health information is handled under HIPAA-compliant practices and encrypted in transit (TLS).
Plain packaging, signature required. Shipping is designed to take 5 to 7 days for most addresses.
Side effects, dose questions, lifestyle support. Message anytime.
No long-term contracts. Cancel anytime by emailing support, no phone calls, no fees.
Essential is a compounded semaglutide injection plan, $179 first month then $299 per month. Performance is a compounded tirzepatide injection plan, $339 first month then $439 per month. Express is a planned compounded sublingual semaglutide ODT option with proposed launch pricing of $199 for the first approved care cycle, then $249 per approved care cycle; enrollment has not opened and it is not available for purchase through Majesta. Final Express availability, pricing, and terms will be confirmed before enrollment.
Take our 2-minute medical assessment. A US-licensed physician reviews your goals, BMI, medical history, and contraindications, then recommends the right plan for you. Where your state's telehealth rules require it, or where the physician decides it is needed, your evaluation also includes a phone or video visit. Essential is our flagship plan. Performance uses the dual GIP and GLP-1 mechanism; whether it fits your history and goals is the physician's call.
The listed Essential and Performance injection plan prices include physician consultation, compounded medication, discreet shipping, and care-team messaging. The included $20 medical consultation fee is collected on a pass-through basis to the licensed physician. These inclusions apply to the injection plans; final Express terms will be confirmed before enrollment.
Yes, with physician approval. The plans are designed so you can start on one and switch as your progress, tolerance, and goals evolve. Plan switches happen with a brief clinical review; message your care team to start one.
Compounded GLP-1 medications are typically self-pay. We do not bill insurance. The Essential and Performance injection plan prices include physician review, compounded medication, shipping, and support. Final Express terms will be confirmed before enrollment. Many HSA and FSA plans allow prescription weight-loss medication; check with your plan administrator and see our HSA/FSA guide.
We will email you when enrollment opens. Nothing is charged until a physician approves treatment.
Start Your AssessmentLast updated July 3, 2026. Pricing reviewed regularly for accuracy.
